HQL
abrdn Life Sciences Investors
HQL
HQL
47 hedge funds and large institutions have $51.1M invested in abrdn Life Sciences Investors in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $47.6M → $51.1M (+$3.54M)
1.16% less ownership
Funds ownership: 12.74% → 11.58% (-1.2%)
Holders
47
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.08M | |
| 2 | +$1.05M | |
| 3 | +$983K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$293K |
| 5 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$288K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$825K | |
| 3 | -$805K | |
| 4 |
NIM
Needham Investment Management
New York
|
-$465K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$196K |